HIGH POINT, N.C.--(BUSINESS WIRE)--Nov. 19, 2018--
vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that company
management will present a corporate overview at the Piper Jaffray 30th
Annual Healthcare Conference on Tuesday, Nov. 27, 2018 at 2:10 p.m. ET
in New York City.
A live webcast of the presentation can be accessed here and
will be archived for 30 days following the presentation at www.vtvtherapeutics.com.
vTv Therapeutics is a clinical-stage biopharmaceutical company engaged
in the discovery and development of orally administered small molecule
drug candidates to fill significant unmet medical needs. vTv has a
pipeline of clinical drug candidates led by programs for the treatment
of Alzheimer’s disease and diabetes as well as treatment of inflammatory
disorders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181119005483/en/
Source: vTv Therapeutics Inc.
Investors:
vTv Therapeutics Inc.
IR@vtvtherapeutics.com
or
Media:
Josh
Vlasto
212-572-5969
PR@vtvtherapeutics.com
